MedPath

Ferring Pharmaceuticals, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.ferringusa.com

A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease

Phase 3
Terminated
Conditions
Prostate Cancer
Interventions
First Posted Date
2016-01-26
Last Posted Date
2022-06-29
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
545
Registration Number
NCT02663908
Locations
🇸🇰

Fakultna nemocnica Nitra, Nitra, Slovakia

🇺🇸

Erlanger Health System, Chattanooga, Tennessee, United States

🇨🇦

J. Giddens Medicine Professional Corporation, Brampton, Ontario, Canada

and more 129 locations

Effectiveness of Cortiment® in Patients With Ulcerative Colitis

Completed
Conditions
Ulcerative Colitis
Interventions
First Posted Date
2015-10-26
Last Posted Date
2019-11-20
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
378
Registration Number
NCT02586259
Locations
🇸🇪

Danderyds sjukhus (there may be other sites in this country), Stockholm, Sweden

🇮🇪

St. Vincent's University Hospital (there may be other sites in this country), Dublin, Ireland

🇩🇪

Magen-Darm-Zentrum, Facharztzentrum Eppendorf (there may be other sites in this country), Hamburg, Germany

and more 3 locations

MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

Phase 4
Completed
Conditions
Infertility
Interventions
First Posted Date
2015-09-18
Last Posted Date
2023-09-21
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
620
Registration Number
NCT02554279
Locations
🇺🇸

California Fertility Partners, Los Angeles, California, United States

🇺🇸

Houston Fertility Institute, Houston, Texas, United States

🇺🇸

Georgia Reproductive Specialists, Sandy Springs, Georgia, United States

and more 32 locations

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely

Phase 2
Terminated
Conditions
Preterm Delivery
Inadequate Milk Production
Interventions
Drug: Placebo
First Posted Date
2015-09-09
Last Posted Date
2024-02-07
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
4
Registration Number
NCT02545127
Locations
🇺🇸

Ferring Investigational Site, San Antonio, Texas, United States

A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate Cancer

Phase 3
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2015-08-18
Last Posted Date
2017-07-05
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
120
Registration Number
NCT02526784
Locations
🇫🇮

Tampereen yliopistollinen sairaala (there may be other sites in this country), Tampere, Finland

🇫🇷

Groupe Hospitalier Pellegrin Tripode (there may be other sites in this country), Bordeaux, France

🇩🇪

Universitaetsklinikum Freiburg (there may be other sites in this country), Freiburg, Germany

Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)

Phase 3
Completed
Conditions
Ulcerative Colitis
Interventions
Drug: Placebo
First Posted Date
2015-08-13
Last Posted Date
2021-03-15
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
228
Registration Number
NCT02522767
Locations
🇺🇸

Research Associates of South Florida, LLC, Miami, Florida, United States

🇺🇸

Biopharma Informatic Inc., Houston, Texas, United States

🇺🇸

Medical Research Center of Florida, Pembroke Pines, Florida, United States

and more 87 locations

Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)

Phase 3
Completed
Conditions
Ulcerative Colitis
Interventions
Drug: Placebo
First Posted Date
2015-08-13
Last Posted Date
2021-11-08
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
276
Registration Number
NCT02522780
Locations
🇭🇺

Vasútegészségügyi Nonprofit Kiemelten Közhasznú Kft. Debreceni Egészségügyi Központja, Debrecen, Hungary

🇱🇻

Latvian Maritime Medicine Centre, Riga, Latvia

🇲🇽

Investigación Biomédica para el Desarrollo de Fármacos, S.A. de C.V., Zapopan, Mexico

and more 91 locations

Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial

Phase 2
Terminated
Conditions
Septic Shock
Interventions
Drug: placebo
First Posted Date
2015-07-27
Last Posted Date
2021-04-06
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
868
Registration Number
NCT02508649
Locations
🇺🇸

Ohio State University, Columbus, Ohio, United States

🇺🇸

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

🇳🇱

Radboud University Nijmegen Medical Centre (there may be other sites in this country), Nijmegen, Netherlands

and more 18 locations

Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer

Phase 1
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2015-06-10
Last Posted Date
2017-10-26
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
15
Registration Number
NCT02468284
Locations
🇨🇳

Peking University Third Hospital (there may be other sites in this country), Beijing, China

A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation

Phase 3
Completed
Conditions
Infertility
Interventions
Drug: highly purified human chorionic gonadotropin
First Posted Date
2015-05-20
Last Posted Date
2019-06-26
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
176
Registration Number
NCT02449889
Locations
🇧🇷

Instituto Ideia Fértil de Saúde Reproductive (there may be other sites in this country), São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath